Published in J Urol on June 01, 1995
Renal transplantation--salvage surgery and suppression. J Urol (1995) 0.75
The injury severity score: a method for describing patients with multiple injuries and evaluating emergency care. J Trauma (1974) 47.36
Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc Natl Acad Sci U S A (1994) 8.13
The injury severity score: an update. J Trauma (1976) 7.33
Renal syndromes associated with nonsteroidal antiinflammatory drugs. N Engl J Med (1984) 6.25
Human beta-defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis. Cell (1997) 5.99
Transduction with recombinant adeno-associated virus for gene therapy is limited by leading-strand synthesis. J Virol (1996) 5.94
Fatal occupational injuries. JAMA (1982) 5.67
Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J Virol (1995) 5.67
Carrying passengers as a risk factor for crashes fatal to 16- and 17-year-old drivers. JAMA (2000) 5.67
Recombinant adeno-associated virus for muscle directed gene therapy. Nat Med (1997) 4.87
A modification of the injury severity score that both improves accuracy and simplifies scoring. J Trauma (1997) 4.76
MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses. Immunity (1994) 4.65
Gene therapy vectors based on adeno-associated virus type 1. J Virol (1999) 4.63
Successful ex vivo gene therapy directed to liver in a patient with familial hypercholesterolaemia. Nat Genet (1994) 4.33
Submucosal glands are the predominant site of CFTR expression in the human bronchus. Nat Genet (1992) 4.12
Geographic variations in mortality from motor vehicle crashes. N Engl J Med (1987) 4.04
Studies on alcaptonuria: 2. Investigations on a case of human alcaptonuria. Biochem J (1947) 4.03
Stable gene transfer and expression of human blood coagulation factor IX after intramuscular injection of recombinant adeno-associated virus. Proc Natl Acad Sci U S A (1997) 3.84
The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface. Proc Natl Acad Sci U S A (1998) 3.83
Correction of the cystic fibrosis defect in vitro by retrovirus-mediated gene transfer. Cell (1990) 3.70
Inactivation of E2a in recombinant adenoviruses improves the prospect for gene therapy in cystic fibrosis. Nat Genet (1994) 3.56
Human beta-defensin 2 is a salt-sensitive peptide antibiotic expressed in human lung. J Clin Invest (1998) 3.51
Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver. Proc Natl Acad Sci U S A (1994) 3.38
Transduction of dendritic cells by DNA viral vectors directs the immune response to transgene products in muscle fibers. J Virol (1998) 3.14
Natural variation in light sensitivity of Arabidopsis. Nat Genet (2001) 2.97
Screening for refractive errors at age 1 year: a pilot study. Br J Ophthalmol (1979) 2.94
Exchange of surface proteins impacts on viral vector cellular specificity and transduction characteristics: the retina as a model. Hum Mol Genet (2001) 2.88
Drowning: epidemiology and prevention. Am J Public Health (1974) 2.88
Replication-defective vector based on a chimpanzee adenovirus. J Virol (2001) 2.86
Acute cytokine response to systemic adenoviral vectors in mice is mediated by dendritic cells and macrophages. Mol Ther (2001) 2.83
Screening for visual defects in preschoolchildren. Br J Ophthalmol (1986) 2.82
Efficacy and safety of adeno-associated viral vectors based on serotype 8 and 9 vs. lentiviral vectors for hemophilia B gene therapy. J Thromb Haemost (2006) 2.81
A comparison of injury death rates in China and the United States, 1986. Am J Public Health (1991) 2.77
Motor vehicle occupant deaths in young children. Pediatrics (1979) 2.75
Fatal house fires in an urban population. JAMA (1983) 2.70
Isolation of highly infectious and pure adeno-associated virus type 2 vectors with a single-step gravity-flow column. Hum Gene Ther (2001) 2.69
Direct gene transfer of human CFTR into human bronchial epithelia of xenografts with E1-deleted adenoviruses. Nat Genet (1993) 2.67
A first attempt to prevent amblyopia and squint by spectacle correction of abnormal refractions from age 1 year. Br J Ophthalmol (1985) 2.65
Gene therapy: adenovirus vectors. Curr Opin Genet Dev (1993) 2.61
A possible nucleotide-binding domain in the tertiary fold of phosphoribosyltransferases. J Biol Chem (1983) 2.60
Firearms and the public health. J Public Health Policy (1980) 2.60
Are female drivers safer? An application of the decomposition method. Epidemiology (1998) 2.60
On lobbies, liberty, and the public good. Am J Public Health (1980) 2.59
Inefficient gene transfer by adenovirus vector to cystic fibrosis airway epithelia of mice and humans. Nature (1994) 2.57
Recombinant IL-12 prevents formation of blocking IgA antibodies to recombinant adenovirus and allows repeated gene therapy to mouse lung. Nat Med (1995) 2.55
[Principles and practice of mass screening for disease]. Bol Oficina Sanit Panam (1968) 2.54
Activation of innate immunity in nonhuman primates following intraportal administration of adenoviral vectors. Mol Ther (2001) 2.53
A model system for in vivo gene transfer into the central nervous system using an adenoviral vector. Nat Genet (1993) 2.53
Anteroapical stunning and left ventricular outflow tract obstruction. Mayo Clin Proc (2001) 2.48
Adenovirus-mediated transfer of the CFTR gene to lung of nonhuman primates: biological efficacy study. Hum Gene Ther (1993) 2.48
The common variant of cystic fibrosis transmembrane conductance regulator is recognized by hsp70 and degraded in a pre-Golgi nonlysosomal compartment. Proc Natl Acad Sci U S A (1993) 2.48
Hybrid vectors based on adeno-associated virus serotypes 2 and 5 for muscle-directed gene transfer. J Virol (2001) 2.46
Age effects and autopsy evidence of disease in fatally injured drivers. JAMA (1970) 2.44
Immune responses to viral antigens versus transgene product in the elimination of recombinant adenovirus-infected hepatocytes in vivo. Gene Ther (1996) 2.43
Prediction of amblyopia and squint by means of refraction at age 1 year. Br J Ophthalmol (1986) 2.35
Recombinant adenovirus deleted of all viral genes for gene therapy of cystic fibrosis. Virology (1996) 2.35
A replication-defective human adenovirus recombinant serves as a highly efficacious vaccine carrier. Virology (1996) 2.35
Upregulation of class I major histocompatibility complex antigens by interferon gamma is necessary for T-cell-mediated elimination of recombinant adenovirus-infected hepatocytes in vivo. Proc Natl Acad Sci U S A (1995) 2.33
Injury mortality among children and teenagers in the United States, 1993. Inj Prev (1996) 2.32
Childhood injury deaths: national analysis and geographic variations. Am J Public Health (1989) 2.26
Effects of high school driver education on motor vehicle crashes, violations, and licensure. Am J Prev Med (1999) 2.25
CD40 ligand-dependent T cell activation: requirement of B7-CD28 signaling through CD40. Science (1996) 2.21
Sequestration of adenoviral vector by Kupffer cells leads to a nonlinear dose response of transduction in liver. Mol Ther (2001) 2.19
A possible role for kinase-associated protein phosphatase in the Arabidopsis CLAVATA1 signaling pathway. Proc Natl Acad Sci U S A (1997) 2.19
The Silent Gallstone: A Ten to Twenty Year Follow-up Study of 112 Cases. Ann Surg (1948) 2.18
Biology of adenovirus vectors with E1 and E4 deletions for liver-directed gene therapy. J Virol (1996) 2.12
Cell transplantation in liver-directed gene therapy. Cell Transplant (1994) 2.12
Long-term improvement of hypercholesterolemia after ex vivo gene therapy in LDLR-deficient rabbits. Science (1991) 2.11
Current surgical management of congenital diaphragmatic hernia: a report from the Congenital Diaphragmatic Hernia Study Group. J Pediatr Surg (1998) 2.09
Stable restoration of the sarcoglycan complex in dystrophic muscle perfused with histamine and a recombinant adeno-associated viral vector. Nat Med (1999) 2.07
Adenovirus-mediated transfer of the CFTR gene to lung of nonhuman primates: toxicity study. Hum Gene Ther (1993) 2.07
Fatal pedestrian collisions: driver negligence. Am J Public Health (1974) 2.06
Expression of alpha v beta 5 integrin is necessary for efficient adenovirus-mediated gene transfer in the human airway. J Virol (1995) 2.05
Purification of recombinant adeno-associated virus vectors by column chromatography and its performance in vivo. Hum Gene Ther (2000) 1.97
Adeno-associated virus as a vector for liver-directed gene therapy. J Virol (1998) 1.94
The innate immune system in cystic fibrosis lung disease. J Clin Invest (1999) 1.93
Benign small bowel tumor. Ann Surg (1975) 1.92
Cathelicidins--a family of multifunctional antimicrobial peptides. Cell Mol Life Sci (2003) 1.89
Successful adenovirus-mediated gene transfer in an in vivo model of human malignant mesothelioma. Ann Thorac Surg (1994) 1.89
Stable transgene expression in rod photoreceptors after recombinant adeno-associated virus-mediated gene transfer to monkey retina. Proc Natl Acad Sci U S A (1999) 1.89
Use of alcohol as a risk factor for bicycling injury. JAMA (2001) 1.87
Augmentation of innate host defense by expression of a cathelicidin antimicrobial peptide. Infect Immun (1999) 1.87
Without guns, do people kill people? Am J Public Health (1985) 1.87
Recruitment of wild-type and recombinant adeno-associated virus into adenovirus replication centers. J Virol (1996) 1.86
Wartime civilian injuries: epidemiology and intervention strategies. J Trauma (1997) 1.86
Who bought the cars in which people are injured? An exploratory study. Am J Public Health (1979) 1.85
Inhalation therapy in asthma: nebulizer or pressurized metered-dose inhaler with holding chamber? In vivo comparison of lung deposition in children. J Pediatr (1999) 1.85
Evaluation of the management of vehicular fatalities secondary to abdominal injury. J Trauma (1972) 1.85
Bacterial phosphorylcholine decreases susceptibility to the antimicrobial peptide LL-37/hCAP18 expressed in the upper respiratory tract. Infect Immun (2000) 1.84
Communicating with the dying. J Med Ethics (1975) 1.84
Fatal unintentional carbon monoxide poisoning in motor vehicles. Am J Public Health (1972) 1.83
Primary malignancies of the small bowel: a report of 96 cases and review of the literature. Ann Surg (1974) 1.82
Single immunizing dose of recombinant adenovirus efficiently induces CD8+ T cell-mediated protective immunity against malaria. J Immunol (1997) 1.80
Filovirus-pseudotyped lentiviral vector can efficiently and stably transduce airway epithelia in vivo. Nat Biotechnol (2001) 1.80
Chloride secretion by canine tracheal epithelium: I. Role of intracellular c AMP levels. J Membr Biol (1982) 1.79
Clearance of adenovirus-infected hepatocytes by MHC class I-restricted CD4+ CTLs in vivo. J Immunol (1995) 1.75
In vivo correction of low density lipoprotein receptor deficiency in the Watanabe heritable hyperlipidemic rabbit with recombinant adenoviruses. J Biol Chem (1994) 1.71
Molecular basis of defective anion transport in L cells expressing recombinant forms of CFTR. Hum Mol Genet (1993) 1.71
Genotype spectrum of ornithine transcarbamylase deficiency: correlation with the clinical and biochemical phenotype. Am J Med Genet (2000) 1.71
Targeting genes: delivery and persistent expression of a foreign gene driven by mammalian regulatory elements in vivo. J Biol Chem (1989) 1.70